|
US6440408B2
(en)
*
|
1996-09-30 |
2002-08-27 |
University Of Arkansas |
Method of treatment
|
|
ATE345139T1
(de)
*
|
1997-08-21 |
2006-12-15 |
Takara Bio Inc |
Karzinostatische wirkstoffe
|
|
ES2439014T3
(es)
*
|
1998-02-20 |
2014-01-21 |
The University Of Miami |
Complejo de péptido antigénico-proteína de choque térmico modificada
|
|
ATE428441T1
(de)
*
|
1998-05-26 |
2009-05-15 |
Genitrix Llc |
Zusammensetzungen und verfahren zur modulation einer immunantwort auf ein antigen durch verabreichung von zytokine-beladenen zellen
|
|
US7030211B1
(en)
*
|
1998-07-08 |
2006-04-18 |
Gemvax As |
Antigenic peptides derived from telomerase
|
|
US6884785B2
(en)
*
|
1999-06-17 |
2005-04-26 |
The Scripps Research Institute |
Compositions and methods for the treatment or prevention of autoimmune diabetes
|
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US8128922B2
(en)
*
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
GB9930591D0
(en)
*
|
1999-12-23 |
2000-02-16 |
Univ London |
Component for vaccine
|
|
JP5087201B2
(ja)
*
|
2000-08-03 |
2012-12-05 |
ジョンズ・ホプキンス・ユニバーシティ |
抗原に小胞体シャペロンポリペプチドを連結した分子ワクチン
|
|
WO2002041913A1
(en)
*
|
2000-11-27 |
2002-05-30 |
Jens Christian Jensenius |
Collectins as adjuvants
|
|
US7507724B2
(en)
|
2001-01-16 |
2009-03-24 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
|
WO2003035683A2
(en)
*
|
2001-10-26 |
2003-05-01 |
Uffe Holmskov |
Surfactant protein-d and atherosclerosis
|
|
US20090110702A1
(en)
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
|
AU2003259109A1
(en)
*
|
2002-07-12 |
2004-02-02 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
CA2495251C
(en)
|
2002-08-14 |
2018-03-06 |
Macrogenics, Inc. |
Fc.gamma.riib-specific antibodies and methods of use thereof
|
|
WO2004018698A2
(en)
*
|
2002-08-20 |
2004-03-04 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
US20040091503A1
(en)
*
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
ATE552843T1
(de)
*
|
2003-02-06 |
2012-04-15 |
Aduro Biotech |
Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen
|
|
US7695725B2
(en)
*
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
CA2515298C
(en)
*
|
2003-02-06 |
2014-04-08 |
Cerus Corporation |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
US9701725B2
(en)
*
|
2003-05-05 |
2017-07-11 |
The Johns Hopkins University |
Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
GB0315991D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Dakocytomation Denmark As |
Standard
|
|
US7842289B2
(en)
*
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
CA2594040A1
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
WO2006081323A2
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
|
US20060188526A1
(en)
*
|
2005-02-24 |
2006-08-24 |
Cunnion Kenji M |
Method for enhancing the immune response to Staphylococcus aureus infection
|
|
AU2006319216B2
(en)
|
2005-11-29 |
2012-09-13 |
Intrexon Actobiotics Nv |
Induction of mucosal tolerance to antigens
|
|
PL2347775T3
(pl)
|
2005-12-13 |
2020-11-16 |
President And Fellows Of Harvard College |
Rusztowania do przeszczepiania komórek
|
|
EP1984004A4
(en)
*
|
2006-01-17 |
2010-03-03 |
Sloan Kettering Inst Cancer |
THE THERAPY REINFORCING GLUCAN
|
|
CA2651962A1
(en)
*
|
2006-05-12 |
2007-12-21 |
Oklahoma Medical Research Foundation |
Anthrax compositions and methods of use and production
|
|
PT2029173T
(pt)
|
2006-06-26 |
2016-11-02 |
Macrogenics Inc |
Anticorpos específicos fc rib e seus métodos de uso
|
|
WO2008024844A2
(en)
*
|
2006-08-22 |
2008-02-28 |
The Johns Hopkins University |
Anticancer combination therapies
|
|
CA3037889C
(en)
|
2007-01-25 |
2022-09-13 |
Intrexon Actobiotics Nv |
Treatment of immune disease by mucosal delivery of antigens
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
|
WO2009039125A1
(en)
*
|
2007-09-17 |
2009-03-26 |
The Schepens Eye Research Institute, Inc. |
Use of ocular neuropeptides as immune adjuvants
|
|
JP5690143B2
(ja)
|
2008-02-13 |
2015-03-25 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
持続的細胞プログラミング装置
|
|
CA2717854C
(en)
|
2008-03-03 |
2019-02-19 |
The University Of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
US8968720B2
(en)
|
2008-03-20 |
2015-03-03 |
University Of Miami |
Heat shock protein GP96 vaccination and methods of using same
|
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
|
CA2787376A1
(en)
|
2010-01-19 |
2011-07-28 |
President And Fellows Of Harvard College |
Engineered opsonin for pathogen detection and treatment
|
|
EP2624873B1
(en)
|
2010-10-06 |
2019-12-04 |
President and Fellows of Harvard College |
Injectable, pore-forming hydrogels for materials-based cell therapies
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
EP3081937B1
(en)
|
2011-07-18 |
2019-11-13 |
President and Fellows of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
|
CN113337402B
(zh)
|
2011-10-17 |
2024-11-29 |
麻省理工学院 |
细胞内传递
|
|
WO2013130875A1
(en)
|
2012-02-29 |
2013-09-06 |
President And Fellows Of Harvard College |
Rapid antibiotic susceptibility testing
|
|
DK2838515T3
(da)
|
2012-04-16 |
2020-02-24 |
Harvard College |
Mesoporøse siliciumdioxidsammensætninger til modulering af immunresponser
|
|
EP2674167A1
(en)
*
|
2012-06-14 |
2013-12-18 |
PLS-Design GmbH |
Controlled activation of complement components for use as endogenous adjuvant
|
|
EP2976642A4
(en)
|
2013-03-15 |
2016-09-21 |
Harvard College |
METHOD AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR RECORDING OF A TARGET UNIT
|
|
EP3848044A1
(en)
|
2013-05-21 |
2021-07-14 |
President and Fellows of Harvard College |
Engineered heme-binding compositions and uses thereof
|
|
EP3848695A1
(en)
|
2013-08-16 |
2021-07-14 |
Massachusetts Institute Of Technology |
Selective delivery of material to cells
|
|
EP3912986B1
(en)
|
2013-12-18 |
2023-12-13 |
President and Fellows of Harvard College |
Crp capture/detection of bacteria
|
|
EP3137105A4
(en)
|
2014-04-30 |
2017-12-27 |
President and Fellows of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
KR20170074235A
(ko)
|
2014-10-31 |
2017-06-29 |
메사추세츠 인스티튜트 오브 테크놀로지 |
면역 세포로의 생체분자의 전달
|
|
CA2964138C
(en)
|
2014-11-14 |
2023-11-14 |
Massachusetts Institute Of Technology |
Disruption and field enabled delivery of compounds and compositions into cells
|
|
US11125739B2
(en)
|
2015-01-12 |
2021-09-21 |
Massachusetts Institute Of Technology |
Gene editing through microfluidic delivery
|
|
HK1247861A1
(zh)
|
2015-01-30 |
2018-10-05 |
President And Fellows Of Harvard College |
用於癌症治疗的肿瘤周围和肿瘤内部材料
|
|
ES2845727T3
(es)
|
2015-02-06 |
2021-07-27 |
Heat Biologics Inc |
Vector que coexpresa una vacuna y moléculas coestimuladoras
|
|
HK1249452A1
(zh)
|
2015-04-10 |
2018-11-02 |
President And Fellows Of Harvard College |
免疫细胞捕获装置及其制备和使用方法
|
|
SG10201912910PA
(en)
|
2015-07-09 |
2020-02-27 |
Massachusetts Inst Technology |
Delivery of materials to anucleate cells
|
|
WO2017024114A1
(en)
|
2015-08-06 |
2017-02-09 |
President And Fellows Of Harvard College |
Improved microbe-binding molecules and uses thereof
|
|
WO2017041051A1
(en)
|
2015-09-04 |
2017-03-09 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to cells comprising a cell wall
|
|
CN115531609A
(zh)
|
2016-02-06 |
2022-12-30 |
哈佛学院校长同事会 |
重塑造血巢以重建免疫
|
|
CN108697778B
(zh)
|
2016-02-16 |
2023-10-03 |
哈佛学院院长等 |
病原体疫苗及其生产和使用方法
|
|
DK3484448T3
(da)
|
2016-07-13 |
2025-06-10 |
Harvard College |
Antigenpræsenterende cellemimetiske stilladser og fremgangsmåder til fremstilling og brug af disse
|
|
IL264557B2
(en)
|
2016-08-02 |
2024-01-01 |
Harvard College |
Biological agents for regulating immune responses
|
|
WO2018071405A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
|
CA3058938A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
WO2019051443A1
(en)
|
2017-09-11 |
2019-03-14 |
Insideoutbio, Inc. |
METHODS AND COMPOSITIONS FOR IMPROVING IMMUNOGENICITY OF TUMORS
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
WO2020092140A2
(en)
|
2018-11-02 |
2020-05-07 |
Insideoutbio, Inc. |
Methods and compositions to induce or suppress immune responses through the use of membrane bound complement split products
|
|
JP2022549270A
(ja)
|
2019-09-23 |
2022-11-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
バイオマテリアルベースの無抗原ワクチンおよびその使用
|